XML 89 R5.htm IDEA: XBRL DOCUMENT v3.20.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash flows (used in) from operating activities    
Net loss $ (7,654) $ (11,914)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,231 693
Share-based compensation 1,619 659
Unrealized foreign exchange loss 1,942 922
Deferred tax expense 389 0
Finance expense 130 796
Loss on change in fair value of convertible promissory notes 0 776
Changes in non-cash working capital items:    
Trade and other receivables (4,584) (3,994)
Prepaids and deposits (942) (335)
Contract acquisition costs (1,467) (685)
Trade and other payables 4,774 2,830
Employee benefit obligations 652 420
Deferred revenue 9,065 5,250
Cash (used in) from operating activities 5,155 (4,582)
Cash flows used in investing activities    
Purchase of property and equipment (1,081) (366)
Purchase of intangible assets (364) 0
Acquisition of business, net of cash acquired (2,450) 0
Cash used in investing activities (3,895) (366)
Cash flows from (used in) financing activities [abstract]    
Payments received on net investment in finance lease 92 87
Repayment of lease obligation (1,106) (879)
Interest income (paid) 317 (432)
Proceeds from exercise of stock options 244 374
Proceeds from issuance of secured debentures, net 0 3,000
Proceeds from drawdown on secured credit facility, net 0 6,858
Proceeds from bought deal offering of common shares 19,029 0
Proceeds from issuance of common shares 165,600 56,261
Share issuance cost (11,607) (3,847)
Repayment of borrowings (299) (14,055)
Cash (used in) from financing activities 172,270 47,367
Net change in cash and cash equivalents during the year 173,530 42,419
Effect of foreign exchange on cash and cash equivalents (150) 103
Cash and cash equivalents, beginning of the period 46,278 3,756
Cash and cash equivalents, end of the year $ 219,658 $ 46,278